AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Aptevo Therapeutics Inc. (APVO)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

4.61

0.06 (1.32%)

At close: Jan 15, 2025, 3:59 PM

4.77

3.47%

After-hours Jan 15, 2025, 04:50 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	n/a	3.11M	12.29M	4.31M	32.42M	23.07M	14.66M	36.43M	33.60M	45.63M	170.00K
Cost of Revenue	567.00K	901.00K	18.99M	17.85M	19.93M	11.21M	5.01M	24.18M	16.93M	16.25M	38.07M
Gross Profit	-567.00K	2.21M	-6.70M	-13.54M	12.50M	11.85M	9.65M	12.25M	16.67M	29.38M	-37.90M
Operating Income	-28.88M	-28.64M	-21.40M	-27.49M	-40.96M	-51.66M	-53.95M	-126.94M	-61.10M	-51.49M	-53.35M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-18.65M	7.01M	-29.41M	-30.92M	-43.06M	-53.69M	-55.89M	-127.75M	-61.34M	-51.71M	-53.34M
Net Income	-17.41M	42.67M	-27.31M	-18.45M	-40.45M	-53.69M	6.97M	-112.42M	-59.32M	-51.12M	-53.34M
Selling & General & Admin	11.77M	13.87M	14.70M	13.95M	16.20M	28.13M	34.58M	38.67M	43.04M	34.28M	15.45M
Research & Development	17.11M	17.88M	18.99M	17.85M	24.76M	35.38M	29.02M	29.52M	34.73M	46.59M	38.07M
Other Expenses	n/a	-1.53M	-8.01M	-1.32M	-2.10M	-2.02M	34.58M	38.67M	43.04M	34.28M	15.45M
Operating Expenses	28.88M	31.75M	33.69M	31.80M	40.96M	63.52M	63.60M	68.18M	77.77M	80.87M	53.52M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	28.88M	31.75M	33.69M	31.80M	40.96M	74.73M	68.61M	92.37M	94.70M	97.12M	53.52M
Income Tax	n/a	-35.66M	-2.10M	-12.47M	-2.62M	-2.02M	-23.30M	-15.34M	-2.02M	-599.00K	-18.00K
Shares Outstanding (Basic)	278.06K	116.36K	106.54K	77.07K	66.30K	36.53K	34.63K	32.86K	32.84K	32.84K	32.84K
Shares Outstanding (Diluted)	278.06K	115.97K	106.54K	77.07K	66.30K	36.53K	34.63K	32.86K	32.84K	32.84K	32.84K
EPS (Basic)	-62.62	366.71	-256.35	-239.38	-610.11	-1.47K	-941.01	-3.42K	-1.81K	-1.56K	-1.62K
EPS (Diluted)	-62.62	367.92	-256.35	-239.38	-610.11	-1.47K	-941.01	-3.42K	-1.81K	-1.56K	-1.62K
EBITDA	-28.31M	-27.74M	-20.26M	-26.09M	-39.53M	-49.27M	-50.82M	-64.40M	-58.19M	-49.47M	-52.69M
Depreciation & Amortization	567.00K	901.00K	1.14M	1.41M	2.23M	2.39M	2.30M	1.90M	2.91M	2.02M	666.00K